Cell Therapeutics

2011 Review: Cell Therapeutics
Motley Fool
Mon, 01/2/12 - 11:08 am
Cell Therapeutics
Is 2012 Make or Break for Cell Therapeutics?
Motley Fool
Thu, 12/29/11 - 10:28 pm
Cell Therapeutics
pixantrone
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Oncothyreon
Keryx
Vical
Aeterna Zentaris
Eli Lilly
JNJ
Elan
Celgene
Pfizer
Gilead
Pharmasset
Threshold Pharmaceuticals
Celldex
Amgen
BioVex
Aveo Pharmaceutical
Amylin
Alkermes
Vertex
Cell Therapeutics
Amarin
ONYX Pharmaceuticals
Vivus
10 Biotech Stock Predictions for 2012
TheStreet.com
Tue, 12/20/11 - 11:13 am
Amgen
FDA
Oncothyreon
Merck KGaA
Vical
GSK
Seattle Genetics
M&A
Celgene
Biomarin
Amag Pharmaceuticals
Momenta
ONYX Pharmaceuticals
Cell Therapeutics
Roche
Aeterna Zentaris
Arena Pharmaceuticals
Vertex
Spectrum Pharmaceuticals
Cell Therapeutics' Wild Week
Motley Fool
Sun, 12/18/11 - 01:27 pm
Cell Therapeutics
pixantrone
cancer
non profit
1 Biotech Soars While Another Crashes
Motley Fool
Sat, 12/10/11 - 12:45 pm
Adeona
Cell Therapeutics
SIGA technologies
PharmAthene
Cell Therapeutics Shares Decline on Offering News
Forbes
Fri, 12/9/11 - 12:04 pm
Cell Therapeutics
stock offering
5 High Risk/Reward Biotechs For 2012
Seeking Alpha
Mon, 12/5/11 - 06:13 pm
ONYX Pharmaceuticals
Vertex Pharmaceuticals
Amarin
Chelsea Therapeutics
Cell Therapeutics
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Cell Therapeutics Inc. Earnings Cheat Sheet: Loss Widens, Falls Below Estimates
Yahoo/Wall St. Cheat Sheet
Tue, 10/25/11 - 11:49 am
earnings
Cell Therapeutics
Cell Therapeutics Efforts Validated
Yahoo/Zacks
Sat, 10/8/11 - 11:43 am
Cell Therapeutics
pixantrone
non-Hodgkin's lymphoma
Good News for Cell Therapeutics
Yahoo/Zacks.com
Thu, 08/25/11 - 12:20 pm
Cell Therapeutics
pixantrone
non-Hodgkin's lymphoma
Europe
Another Day, Another Loss For Cell Therapeutics
Motley Fool
Sat, 07/30/11 - 09:52 am
Cell Therapeutics
Cell Therapeutics and Neoprobe Hope to Make 2011 a Banner Year
Fri, 07/29/11 - 10:55 pm
Cell Therapeutics
Neoprobe
9 Small Biotechs Near 52-Week Lows
Motley Fool
Sat, 07/23/11 - 03:11 pm
MannKind
Alnylam
Theratechnologies
Metabolix
Cell Therapeutics
Novavax
AVI BioPharma
Allos
Vanda
The 15 Most-Watched Biotech Stocks
Motley Fool
Mon, 07/11/11 - 06:52 pm
biotech
Gilead Sciences
Dendreon
PDL Biopharma
Cell Therapeutics
Amgen
Aeterna Zentaris
Xoma
Geron
Orexigen
Zalicus
Spectrum Pharmaceuticals
Ariad Pharmaceuticals
Biogen Idec
Momenta
StemCells
Cell Therapeutics CEO Bianco sees turnaround
bizjournals.com
Sat, 07/9/11 - 10:53 am
Cell Therapeutics
Dendreon Leads the 'Now Generation' For Cancer Immunotherapeutic Treatment
Seeking Alpha
Mon, 07/4/11 - 09:20 am
Dendreon
prostate cancer
cancer immunotherapy
Cel-Sci
Cell Therapeutics
ImmunoCellular
Keryx
Teva Pharmaceuticals
Oncothyreon
Biotech Data Mining Comes Up Empty
TheStreet.com
Wed, 06/29/11 - 10:26 am
data mining
Cel-Sci
Apricus Biosciences
Osiris
Transdel
Agenus
Introgen
Cell Therapeutics
Will Cell Therapeutics Innovate or Die?
Motley Fool
Wed, 06/22/11 - 10:21 pm
Cell Therapeutics
innovation

Pages